Abstract |
Three different antibiotic regimens ( trospectomycin plus azteonam, clindamycin plus azteonam, and triple antibiotics- ampicillin plus clindamycin plus gentamicin) were all effective in treating patients with postcesarean endometritis. Patients are frequently cured clinically despite the fact that the offending organisms may be isolated in post-treatment cultures. Treatment of postcesarean endometritis without obtaining endometrial cultures is acceptable gynecologic practice. Obtaining post-treatment cultures is clearly not cost effective nor clinically beneficial. Drug treatment efficacy should be evaluated by clinical response. This communication is the first to report the new antibiotic, trospectomycin, in the treatment of postcesarean endometritis. Further clinical trials are currently underway.
|
Authors | L Filler, C F Shipley 3rd, E J Dennis 3rd, G H Nelson |
Journal | Journal of the South Carolina Medical Association (1975)
(J S C Med Assoc)
Vol. 88
Issue 6
Pg. 291-5
(Jun 1992)
ISSN: 0038-3139 [Print] United States |
PMID | 1385635
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Bacterial Agents
- trospectomycin
- Spectinomycin
|
Topics |
- Anti-Bacterial Agents
(therapeutic use)
- Cesarean Section
- Double-Blind Method
- Endometritis
(drug therapy, microbiology)
- Female
- Humans
- Postoperative Complications
(drug therapy)
- Pregnancy
- Puerperal Infection
(drug therapy, microbiology)
- Spectinomycin
(analogs & derivatives, therapeutic use)
|